New Drugs and Clinical Trials Rules 2019

COVID-19: The Importance of Conditional Indemnity for Vaccine Makers

India’s Vaccine Approvals Had One Problem. It Gave Rise To the Other Two.

DCGI’s Covaxin Verdict Forces First Vaccine Recipients To Make a Tough Call

There Are More Questions We Need to Ask About the COVAXIN Clinical Trials

India Set up a Code to Use Experimental Drugs in an Outbreak – Then Ignored It